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place special emphasis on the detection of subclinical left ventri-
cular (LV) systolic and diastolic dysfunction and the timely identi-
ﬁcation of risk factors for HF. Our goal was to describe the
prevalence and determinants (risk factors) of LV diastolic dysfunc-
tion in asymptomatic elderly populationwhich is expected to have
higher prevalence of diastolic dysfunction.
Methods: We evaluated 103 asymptomatic elderly populations at
random in the LTMG Hospital, Mumbai from January 2015 to June
2015. For this we have included the patient's relatives who were
beyond 60 years of age with LV ejection fraction ≥60%. Patients
with organic heart disease were excluded from the study. Data on
demographics, baseline characteristics, andmedical therapieswas
collected. In a randomly recruited population sample (n = 103;
53.3% women; mean age, 67.9 years), we measured early and late
diastolic peak velocities of mitral inﬂow (E and A), pulmonary vein
ﬂow by pulsed-wave Doppler, and themitral annular velocities (Ea
and Aa) at 4 sites by tissue Doppler imaging. Stata SE 13.1 was used
to analyse data. Fishers Exact test was applied to test the relation-
ship of categorised independent and dependent variables.
Results: In the study population of 103, overall prevalence of
diastolic dysfunction was 63.10% with the number of subjects in
diastolic dysfunction groups 1 (impaired relaxation), 2 (elevated LV
end-diastolic ﬁlling pressure), and 3 (elevated E/Ea and abnormally
low E/A) were 43 (41.74%), 18 (17.47%), and 4 (3.88%), respectively
(Table 1).We used Ar-A > 30 ms to conﬁrm possible elevation of LV
ﬁlling pressures in group 2. Only 38 (36.89%) patients had normal
diastolic function. Predictors of diastolic dysfunction in elderly
were identiﬁed as age >70 years ( p = 0.02), type 2 DM ( p = 0.03),
and smoking ( p = 0.05), though we did not ﬁnd any signiﬁcant
difference correlating diastolic dysfunction with sex ( p = 0.09)
and hypertension ( p = 0.1) (Table 2).
Conclusions: The overall prevalence of LV diastolic dysfunction
in a random sample of an elderly population is as high as
63.10% with advanced age being the best predictor of diastolic
dysfunction followed by diabetes mellitus and smoking, though
gender and hypertension failed to predict the presence of diastolic
dysfunction.
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Introduction: India is now estimated to be the coronary artery
disease (CAD) capital of the world. CAD among women as a group
is less easily recognized worldwide and this problem is especially
relevant in a developing country like India.
Aims and methods: Fifty female patients of STEMI, aged less than
65 years (mean 49 years) were assessed by clinical, biochemical,
and coronary angiographic study. Main parameters observed were
time of presentation and angiographic severity.
Results: Average duration of presentation to hospital from symp-
tom onset was 28 h and only 30% (n = 15) patients presentedwithin
window period of 12 h. Single vessel disease (SVD) was noted in
70% (n = 35) patients. Double (DVD) and triple vessel disease (TVD)
was seen in 16% (n = 8) and 14% (n = 7), respectively. Among speciﬁc
coronary artery disease, LAD was involved in 78% (n = 39), LCX 26%
(n = 13), and RCA 26% (n = 13). LMCA was involved in 8% (n = 4)
cases.
Conclusion: This study reiterates the need of establishing systems
for early recognition and awareness of CAD among women in
India. As SVD is more common, complete revascularization
through PCI is feasible and economically viable in this segment
of the Indian population.
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Rationale: The choice of newer anti-platelet therapies and strate-
gies is continuously evolving as well as the International guide-
lines for their use. The available data concerning the usage pattern
of newer anti-platelet therapies in ACS patients is largely derived,
essentially from clinical trials. The TREASURE observational study
is designed to address the need to understand the usage pattern of
Ticagrelor in real life scenario in large number of ACS patients in
India.
The multicenter national participation will allow generating real
life evidence by involving patients from different geographies and
healthcare systems in India.
Objectives: To describe the usage pattern of Ticagrelor in various
ACS patient population who undergo either PCI, CABG, or medical
management in a real-life setting in India. Also to record various
risk factors (i.e. elderly patients, diabetes, renal impairment, smok-
ing, risk score, and their association with ACS and usage of Tica-
grelor).
Methods: This is an observational, multi-centric, prospective
study. Study intends to include 3000 subjects from 60 sites across
India. Key inclusion criteriawould be provision of subject informed
Table 1
Echo
parameters
(mean)
Normal
function
N = 38
(36.89%)
Grade I
N = 43
(41.74%)
Grade II
N = 18
(17.47%)
Grade III
N = 4
(3.88%)
LA (mm) 38.8 40.6 42.5 41.4
LV (mm) 50.3 50.7 50.5 48.5
IVS (mm) 9.6 10.4 10.8 12.2
PW (mm) 8.5 9.2 9.6 10.4
EF (%) 68.4 66 71.8 71.6
E peak (cm/s) 78.3 53.8 81.3 63
A peak (cm/s) 60.6 78.9 82.2 96.2
E/A 1.37 0.7 1.02 0.65
IVRT (ms) 98.3 114.9 108.5 107.1
Ea peak 12.7 8.28 7.8 5.94
Aa peak 10.2 12.1 10.5 11.6
E/Ea ratio 6.37 6.66 10.6 10.7
Table 2
Normal
diastolic
function
N = 38
Diastolic
dysfunction
N = 65
p value
Age (mean) 65 71 0.02
Male (n, %) 14 (36.84) 34 (52.30) 0.09
Smoker 7 (18.42) 29 (44.61) 0.05
Diabetic 15 (39.47) 39 (60) 0.03
Hypertensive 20 (52.63) 37 (56.92) 0.10
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consent patients who had been hospitalized for ACS and are on
Ticagrelor on discharge or on Ticagrelor therapy for ≤1 month will
be enrolled in the study and followed up for a period of 12 months.
Demographic data, diagnosis (type of ACS), management of ACS,
laboratory investigations, relevant history, and physical examina-
tion will be collated.
Results: Study is expected to ﬁll a signiﬁcant gap existing in our
knowledge to understand the usage pattern of Ticagrelor in real life
scenario in large number of ACS patients in India. The aim of this
national study is to understand the usage pattern (including the
durationof treatment) of Ticagrelor invariousACSpatientpopulation
undergoingPCI,CABG,ormedicalmanagement ina real-lifesetting in
India.Moreover,patientswithvarious risk factors (i.e. elderlypatients,
diabetes, renal impairment, smoking, GRACE risk score) and their
association with ACS and Ticagrelor usage will be measured.
The study started in May 2015 and approximately 100 patients
have been enrolled till date.
Conclusion: The multicenter national study will allow generating
real life evidence by involving patients from different geographies
and healthcare systems in India. The study is intended to provide
useful evidence of the Ticagrelor usage in variety of ACS patients in
actual hospital settings.
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Background: SYNTAX score is an objective scoring system to assess
severity and extent coronary artery disease. To evaluate the prognos-
tic value of the SYNTAX score in predicting in-hospital mortality in
coronary artery bypass patients, at a tertiary centre in India.
Methods: A cohort of 325 patients who underwent coronary artery
bypass surgery were included in this study from July 2012 to May
2014. They were divided into tertiles according to the SYNTAX
score (0–22, 23–33, and above 33). The endpoint was in-hospital
mortality.
Results: The mortality in SS tertiles were as follows: 0–22 = 6%; 23–
33 = 4.2%, and above 33 = 14.3%. There was signiﬁcant increase in
mortality in the third tertile ( p = 0.0297). SS above 33 had an odd's
ratio of 3.036 ( p = 0.018) for mortality.
Conclusion: Severity of coronary artery disease as measured by SS
of more than 33 is a signiﬁcant predictor of mortality after CAB
surgery.
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Background: Platelet activation and aggregation has been
implicated in the pathogenesis of atherosclerosis and in the
development of acute thrombotic event. Platelet volume is a mar-
ker of platelet activation and function, and is measured using
mean platelet volume (MPV).
Aim: To investigate the relationship between MPV and angio-
graphic severity of coronary artery disease in terms of SYNTAX
score, both in stable angina and acute coronary syndromes.
Methods: In this study, a total of 160 patients were evaluated who
presented with suspected CAD on clinical grounds. All patients
underwent routine biochemical examination, complete blood
count, and coronary artery angiography using standardized pro-
tocol. SYNTAX score was calculated using online software and
correlation between MPV and coronary lesion severity was ana-
lysed using statistical software.
Results: Out of 160 patients, 37 (23.12%) patients presented with
CSA and 104 (65%) patients with ACS; out of which 29 (18.12%)
patients diagnosed with UA or NSTEMI and 75 (46.87%) patients
with STEMI; 19 (11.87%) patients had normal coronary angio-
gram, allocated to control group. Mean age of the CSA patients
was 58.16  11.48 years, while in UA&NSTEMI and STEMI group it
was 52.10  8.52 years and 53.99  11.83 years, respectively.
51.21  9.43 years was the mean age in control group. 129
(80.6%) patients were male and 31 (19.4%) patients were female.
ACS patients, i.e. UA&NSTEMI and STEMI patients had signiﬁ-
cantly higher MPV value than CSA and control group (8.86  1.07,
8.83  0.73 fL vs 8.42  0.81, 7.50  0.18 fL; p < 0.001). Mean SYN-
TAX score in CSA group was 16.54  8.10 in male and 17.83  7.41
in female; in UA&NSTEMI group, 19.27  9.85 in male and 9.92
 9.89 in female with p value of 0.049. In STEMI group mean
SYNTAX score was 19.73  7.27 in male and 17.75  2.79 in
female. In low SYNTAX score group MPV values were signiﬁ-
cantly more in UA&NSTEMI patients and STEMI patients than
CSA and control group (8.37  0.76, 8.59  0.62 fL vs 8.09  0.62,
7.50  0.18 fL; p < 0.001). In intermediate and high SYNTAX score
group MPV did not differ signiﬁcantly. MPV was signiﬁcantly
more in intermediate and high SYNTAX score category than low
SYNTAX score, in all the three study groups. According to Pear-
son correlation analysis there was large positive relationship
between MPV and SYNTAX score in all the three study groups.
ROC curve analysis showed cut-off values of MPV for predicting
the severity of SYNTAX score, were >7.7 fL for CSA group and
>8 fL for ACS patients.
Conclusion: We found that higher MPV values are signiﬁcantly
associated with acute coronary syndromes than stable angina;
higher the MPV value more severe and complex is the coronary
artery disease, as demonstrated by the SYNTAX score analysis.
MPV can be considered a marker of platelet reactivity or a risk
factor for CAD. Large scale, randomized controlled trials are
needed for further clariﬁcation.
Role of tirofiban in postinfarction
angina who refused for early
intervention – Our hospital experience
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Background: Postinfarction angina is not an uncommon complica-
tion after myocardial infarction (MI). Because of its high risk score
(Unstable Angina class III, Risk score 9 if rest angina <48 h post MI)
guidelines recommend early intervention in these patients. How-
ever, ﬁnancial constraints and lack of wide insurance coverage in
developing countries prohibit intervention in these patients. That
is why we analysed the addition of tiroﬁban (GpIIb/IIIa inhibitor)
which acts by inhibiting platelet aggregation a key mechanism in
postinfarction angina.
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